NO20011693D0 - Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser - Google Patents
Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelserInfo
- Publication number
- NO20011693D0 NO20011693D0 NO20011693A NO20011693A NO20011693D0 NO 20011693 D0 NO20011693 D0 NO 20011693D0 NO 20011693 A NO20011693 A NO 20011693A NO 20011693 A NO20011693 A NO 20011693A NO 20011693 D0 NO20011693 D0 NO 20011693D0
- Authority
- NO
- Norway
- Prior art keywords
- carnitines
- resveratrol
- cerebral
- prevention
- treatment
- Prior art date
Links
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 title 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 title 1
- 230000032683 aging Effects 0.000 title 1
- 230000002490 cerebral effect Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 229940016667 resveratrol Drugs 0.000 title 1
- 235000021283 resveratrol Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Botany (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1998RM000636A IT1302365B1 (it) | 1998-10-09 | 1998-10-09 | Uso di carnitine e resveratrolo per produrre una composizione per laprevenzione o il trattamento terapeutico di alterazioni cerebrali |
PCT/IT1999/000311 WO2000021526A1 (en) | 1998-10-09 | 1999-10-06 | Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20011693D0 true NO20011693D0 (no) | 2001-04-04 |
NO20011693L NO20011693L (no) | 2001-04-04 |
Family
ID=11406160
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20011693A NO20011693L (no) | 1998-10-09 | 2001-04-04 | Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser |
Country Status (27)
Country | Link |
---|---|
US (1) | US6515020B1 (ko) |
EP (1) | EP1117394B1 (ko) |
JP (1) | JP4166951B2 (ko) |
KR (1) | KR20010079981A (ko) |
CN (1) | CN1323205A (ko) |
AR (1) | AR020762A1 (ko) |
AT (1) | ATE249823T1 (ko) |
AU (1) | AU767492B2 (ko) |
BR (1) | BR9915918A (ko) |
CA (1) | CA2344893C (ko) |
CZ (1) | CZ2001920A3 (ko) |
DE (1) | DE69911441T2 (ko) |
DK (1) | DK1117394T3 (ko) |
EE (1) | EE200100205A (ko) |
ES (1) | ES2207287T3 (ko) |
HK (1) | HK1040935A1 (ko) |
HU (1) | HU229364B1 (ko) |
IL (1) | IL142046A0 (ko) |
IS (1) | IS5896A (ko) |
IT (1) | IT1302365B1 (ko) |
NO (1) | NO20011693L (ko) |
PL (1) | PL197342B1 (ko) |
PT (1) | PT1117394E (ko) |
SK (1) | SK3782001A3 (ko) |
TN (1) | TNSN99186A1 (ko) |
TR (1) | TR200100947T2 (ko) |
WO (1) | WO2000021526A1 (ko) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002047193A (ja) * | 2000-07-31 | 2002-02-12 | Sunstar Inc | アレルギー性皮膚炎予防または治療用組成物 |
US20020173511A1 (en) * | 2000-11-08 | 2002-11-21 | Wurtman Richard J. | Serotonergic compositions and methods for treatment of mild cognitive impairment |
BRPI0106382B1 (pt) * | 2001-03-13 | 2017-07-11 | Universidade Do Estado Do Rio De Janeiro - Uerj | Process for obtaining decocts from vitis labrusca and vitis vinifera casts, process for obtaining the hydro-alcoholic extract, process for obtaining the hydro-alcoholic extract-ethyl acetate and pharmaceutical compositions |
DE50111204D1 (de) * | 2001-08-18 | 2006-11-23 | Cognis Ip Man Gmbh | Wirkstoffmischungen |
US20070218152A1 (en) * | 2002-03-12 | 2007-09-20 | Roberto Moura | Process for obtention of decoctions of Vitis labrusca and Vitis vinifera skins |
US7977049B2 (en) * | 2002-08-09 | 2011-07-12 | President And Fellows Of Harvard College | Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
KR100574392B1 (ko) * | 2003-02-07 | 2006-05-02 | 재단법인서울대학교산학협력재단 | 신경보호활성을 갖는 신규 페닐환 유도체 및 이를함유하는 약학 조성물 |
EP2236131A3 (en) * | 2003-07-01 | 2011-03-02 | President and Fellows of Harvard College | Sirt1 modulators for manipulating cell/organism lifespan/stress response |
US20060025337A1 (en) * | 2003-07-01 | 2006-02-02 | President And Fellows Of Harvard College | Sirtuin related therapeutics and diagnostics for neurodegenerative diseases |
KR100543056B1 (ko) * | 2003-11-07 | 2006-01-20 | (주)네추럴에프앤피 | 신경세포 보호 활성이 있는 포도씨 추출물을 포함하는뇌질환 예방 및 치료용 조성물 |
EP1708689A2 (en) | 2003-12-29 | 2006-10-11 | The President and Fellows of Harvard College | Compositions for treating or preventing obesity and insulin resistance disorders |
US8017634B2 (en) | 2003-12-29 | 2011-09-13 | President And Fellows Of Harvard College | Compositions for treating obesity and insulin resistance disorders |
ES2245609B1 (es) * | 2004-06-18 | 2007-08-16 | Universidad De Barcelona | Nuevo agente terapeutico para el tratamiento de la infertilidad y/o subfertilidad masculina en mamiferos. |
US20060014705A1 (en) * | 2004-06-30 | 2006-01-19 | Howitz Konrad T | Compositions and methods for selectively activating human sirtuins |
US20060121137A1 (en) * | 2004-12-07 | 2006-06-08 | Hartle Diane K | Muscadine grape pomace in the treatment of intestinal inflammation |
CA2595159A1 (en) * | 2005-01-13 | 2006-07-20 | Sirtris Pharmaceuticals, Inc. | Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders |
WO2006138418A2 (en) | 2005-06-14 | 2006-12-28 | President And Fellows Of Harvard College | Improvement of cognitive performance with sirtuin activators |
CN101296693B (zh) * | 2005-10-26 | 2012-07-04 | 花王株式会社 | 持久力提高剂 |
FR2898493B1 (fr) * | 2006-03-16 | 2008-08-08 | Af Consulting | Compositions cosmetiques, pharmaceutiques, alimentaires et veterinaires dont l'action d'activation de genes de type sirtuin permet de retarder le vieillissement des mammiferes et ses effets nefastes |
US20120016037A1 (en) * | 2006-07-24 | 2012-01-19 | Frank Toppo | Method for prevention and treatment of Alzheimers |
MX2009008022A (es) * | 2007-01-26 | 2009-12-11 | Univ Washington | Metodos y composiciones para tratar neuropatias. |
AT506014A1 (de) * | 2007-10-24 | 2009-05-15 | Karl Mag Dr Zehethofer | Functional drink |
SG10201503032UA (en) | 2010-06-16 | 2015-06-29 | Sigma Tau Ind Farmaceuti | Acetyl-carnitine for use in a method for increasing neurogenesis in neural tissue |
KR101327936B1 (ko) * | 2011-07-06 | 2013-11-13 | 한국식품연구원 | 옥시레스베라트롤 이민 유도체를 유효성분으로 함유하는 뇌신경보호 효과를 가지는 조성물 |
CN102919943A (zh) * | 2012-10-26 | 2013-02-13 | 郑全辉 | 保健饮品-葡藤素 |
CN103877170B (zh) * | 2012-12-19 | 2015-11-04 | 中国医学科学院药用植物研究所 | 一种虎杖的乙酸乙酯提取物及其制备方法和应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4346107A (en) * | 1979-02-12 | 1982-08-24 | Claudio Cavazza | Pharmaceutical composition comprising acyl-carnitine for the treatment of impaired cerebral metabolism |
IT1276225B1 (it) * | 1995-10-17 | 1997-10-27 | Sigma Tau Ind Farmaceuti | Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per |
IT1283967B1 (it) * | 1996-03-29 | 1998-05-07 | Sigma Tau Ind Farmaceuti | Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi |
AU6141498A (en) * | 1997-02-04 | 1998-08-25 | John V. Kosbab | Compositions and methods for prevention and treatment of vascular degenerative diseases |
IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
CH692837A5 (it) * | 1997-07-02 | 2002-11-29 | Lisapharma Spa | Composizione farmaceutica per uso alimentare, dietetico o medicinale adatta a migliorare l'assorbimento orale dei polifenoli e particolarmente del resveratrolo presenti nell'uva e nei suoi p |
US5904924A (en) * | 1997-11-04 | 1999-05-18 | Oncologics, Inc. | Green nutritional powder composition |
AU4084599A (en) * | 1998-05-18 | 1999-12-06 | Oklahoma Medical Research Foundation | Resveratrol inhibition of myeloperoxidase |
-
1998
- 1998-10-09 IT IT1998RM000636A patent/IT1302365B1/it active IP Right Grant
-
1999
- 1999-10-05 TN TNTNSN99186A patent/TNSN99186A1/fr unknown
- 1999-10-06 EE EEP200100205A patent/EE200100205A/xx unknown
- 1999-10-06 KR KR1020017004267A patent/KR20010079981A/ko not_active Application Discontinuation
- 1999-10-06 AT AT99947853T patent/ATE249823T1/de active
- 1999-10-06 EP EP99947853A patent/EP1117394B1/en not_active Expired - Lifetime
- 1999-10-06 JP JP2000575502A patent/JP4166951B2/ja not_active Expired - Fee Related
- 1999-10-06 CA CA002344893A patent/CA2344893C/en not_active Expired - Fee Related
- 1999-10-06 DE DE69911441T patent/DE69911441T2/de not_active Expired - Lifetime
- 1999-10-06 SK SK378-2001A patent/SK3782001A3/sk unknown
- 1999-10-06 PT PT99947853T patent/PT1117394E/pt unknown
- 1999-10-06 DK DK99947853T patent/DK1117394T3/da active
- 1999-10-06 TR TR2001/00947T patent/TR200100947T2/xx unknown
- 1999-10-06 PL PL347209A patent/PL197342B1/pl not_active IP Right Cessation
- 1999-10-06 AU AU61213/99A patent/AU767492B2/en not_active Ceased
- 1999-10-06 WO PCT/IT1999/000311 patent/WO2000021526A1/en not_active Application Discontinuation
- 1999-10-06 CN CN99811952A patent/CN1323205A/zh active Pending
- 1999-10-06 BR BR9915918-0A patent/BR9915918A/pt not_active Application Discontinuation
- 1999-10-06 HU HU0104021A patent/HU229364B1/hu unknown
- 1999-10-06 ES ES99947853T patent/ES2207287T3/es not_active Expired - Lifetime
- 1999-10-06 IL IL14204699A patent/IL142046A0/xx unknown
- 1999-10-06 CZ CZ2001920A patent/CZ2001920A3/cs unknown
- 1999-10-06 US US09/806,454 patent/US6515020B1/en not_active Expired - Fee Related
- 1999-10-08 AR ARP990105115A patent/AR020762A1/es unknown
-
2001
- 2001-03-16 IS IS5896A patent/IS5896A/is unknown
- 2001-04-04 NO NO20011693A patent/NO20011693L/no not_active Application Discontinuation
-
2002
- 2002-04-17 HK HK02102885.2A patent/HK1040935A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20011693D0 (no) | Kombinasjon av karnitiner og resveratrol for forebygging eller behandling av cerebrale og aldringsforstyrrelser | |
NO20022585D0 (no) | Pyrrolidinacetamidderivat alene eller i kombinasjon for behandling av CNS-forstyrrelser | |
PL348817A1 (en) | Compositions and methods for the treatment of anorectal disorders | |
HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
NO20004098D0 (no) | FremgangsmÕter og preparater for behandling av makrofag- formidlede lidelser | |
NO20054913D0 (no) | Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser | |
IL128379A0 (en) | Treatment of the common cold or allergic rhinitis | |
NO20010401L (no) | FremgangsmÕte for Õ fjerne og hindre oppbygning av forurensninger i prosesser for papirfremstilling | |
NO20033443L (no) | Anvendelse av CD-2-bindende midler ved behandling eller forebygging av hudlidelser | |
NO20001412D0 (no) | Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser | |
DK1218022T3 (da) | Sammensætning til forebyggelse og/eller behandling af kredsløbslidelser omfattende derivater af L-carnitin og ekstrakter af Ginkgo Biloba | |
DK1041985T3 (da) | Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme | |
NO20010456L (no) | Triazolopyridiner for behandling av trombose lidelser | |
AU1742200A (en) | Prevention and treatment of amyloid-associated disorders | |
NO20012106L (no) | Middel for behandling av forstyrrelser i benmetabolismen | |
AU5006499A (en) | Compositions and methods for the treatment or prevention of pulmonary infections | |
FR2755609B1 (fr) | Composition pour la prevention du vieillissement cutane | |
ITRM990707A0 (it) | Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil l-carni | |
HUP0204209A3 (en) | Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms | |
HUP0303963A2 (hu) | Figyelemhiányban/hiperaktivitásban szenvedő gyermekek tanulási rendellenességeinek megelőzésére vagy kezelésére szolgáló kompozíció | |
DK1140119T3 (da) | Anvendelse af heparin med lav molekylvægt til forebyggelse og/eller behandling af motorneuronale sygdomme | |
NO982818D0 (no) | Syntetisk fremstilt preparat for behandling og/eller profylakse av overvekt, samt anvendelse derav | |
BR9710546A (pt) | Formula-Æo para o tratamento e/ou profilaxia de dem-ncia | |
EP0893123A4 (en) | MEANS OF PREVENTIVE AND CURATIVE TREATMENT OF CONDITIONS RELATED TO DIFFERENT FORMS OF AGING OF THE ORGANISM | |
DK1249245T3 (da) | Hjælpemiddel og/eller profylaktisk middel til behandling af nervesystemsforstyrrelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |